THE INVOLVEMENT OF LACTOFERRIN IN THE HYPOSIDEREMIA OF ACUTE INFLAMMATION by van Snick, Jacques L. et al.
THE  INVOLVEMENT  OF  LACTOFERRIN  IN  THE 
HYPOSIDEREMIA  OF  ACUTE  INFLAMMATION* 
BY  JACQUES L.  VAN  SNICK,  PIERRE L.  MASSON,  AND JOSEPH  F.  HEREMANS 
(From the Department of Experimental Medicine, University of Louvain, B-1200 Bruxelles, Belgium) 
The concentration of iron in the plasma decreases  during inflammation (1); it will, for 
instance, drop very sharply within 12 h after the injection of bacterial endotoxin (2) or the 
production of a turpentine abscess (3). This hyposideremia corresponds to the accumula- 
tion of iron,  in the form  of ferritin, in  inflamed tissues  and  in  the reticuloendothelial 
system (RES)  (1,  4). Blockade of the latter prevents the development of hyposideremia 
(3). 
On  the  other  hand,  neutrophilic  leukocytes  are  required  for  the  development of 
inflammatory hyposideremia, as shown by experiments with leukopenic animals (2, 5, 6). 
Kampschmidt and Upchurch (6), as well as Pekarek and Beisel (7) have attempted to 
characterize a  leukocyte factor responsible  for  the  phenomenon.  Our  own  group  has 
proposed (8)  to explain the hyposideremia of inflammation, as being mediated by an 
iron-binding protein, lactoferrin, whose presence in the specific granules of neutrophilic 
leukocytes we have described (9, 10). 
Lactoferrin is a glycoprotein sharing several biochemical properties (11-13) with 
transferrin. These two proteins have the same molecular weight (14)  and both 
will reversibly bind two ferric ions with the incorporation of two molecules of 
bicarbonate (15). By their amino acid composition (14)  they are clearly related, 
although they fail to show any immunological cross-reaction unless denatured 
(16).  Lactoferrin further differs from  transferrin  by its  affinity for iron  being 
largely  retained  at  pH  values  below  4.0  (11-13,  17),  whereas  under  such 
conditions transferrin completely releases its iron. Yet another difference resides 
in  the  histological  distribution  of the  two  proteins.  Whereas  transferrin  is  a 
plasma  protein synthesized mainly by the liver (18),  lactoferrin occurs in the 
plasma  only in  trace amounts,  but  abounds  in external secretions (8,  19)  and 
neutrophils (9). 
The present report will deal with experiments demonstrating that lactoferrin 
plays  a  determinant role  in  inflammatory hyposideremia. It  is  proposed that 
iron-free lactoferrin (apolactoferrin), when  released from neutrophils,  removes 
the iron from transferrin and, together with its load of iron, is selectively taken up 
by the RES. 
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Materials and Methods 
Reagents.  Zymosan  was  obtained  from  Koch-Light  Laboratories,  Ltd.,  Colnbrook,  England; 
endotoxin  (Escherichia  coil  0.55:85  lipopolysaccharide  B)  from  Difco  Laboratories,  Inc.,  Detroit, 
Mich.; and human transferrin devoid of iron (apotransferrin) from Behring-Institut, Marburg,  W. 
Germany. 
Human lactoferrin was isolated from milk by chromatography on carboxymethyl-Sephadex (14). 
Some batches were prepared after saturation of the protein with iron (Fe-lactoferrin). One sample 
was isolated in a form poor in iron (13% saturation calculated from the absorbance at 460 nm). The 
latter sample will be referred to as native apolactoferrin, to distinguish it from the protein artificially 
deprived of iron by dialysis against 0.1 M  citric acid (14). 
Goat antiserum against the proteins extracted from rat heterophil leukocytes was obtained by 
repeated injections of material from 108 leukocytes. After absorption with rat plasma, this antiserum 
developed  several  precipitin  lines with  the  immunizing antigen.  The  line  due  to  lactoferrin was 
identified by autoradiography as described in the Results (Fig. 6). 
Rabbit antiserum specific for rat lactoferrin was obtained as follows. Rat lactoferrin was isolated 
from extracts of peritoneal exudates (see below) by small-scale preparative electrophoresis in agarose 
gel at pH 8.6. The zone of gel containing lactoferrin was disrupted in 1 M  saline by repeated freezing 
and thawing, and samples of this material containing 100-200 pg of protein were  injected at 2-wk 
intervals into the foot pads of a rabbit. Freund's complete adjuvant was added to the first two doses of 
antigen. The antiserum was collected 1 wk after the fourth injection. After absorption with rat plasma 
it was found to be specific for lactoferrin, when tested with extracts of rat heterophil leukocytes (Fig. 
6). 
A goat antiserum directed against succinylated human lactoferrin was obtained by intradermally 
injecting, every 2 wk,  100 pg of succinylated Fe-lactoferrin suspended in 1 ml of complete Freund's 
adjuvant. Succinylation was carried out by dissolving 50 mg of Fe-lactoferrin in 3 ml of 0.2 M  NaC1 
and 0.1 M  NaHCO3 and treating the protein at room temperature with 25 rag of succinic anhydride, 
added slowly over 1 h. The pH was maintained at 8.5 by addition of 0.1 M  NaOH. 
Specific  antisera  against  human  or  rabbit  lactoferrin  were  prepared  in  goats,  as  previously 
described  (9,  10).  Goat  antisera  against  human  albumin  and  transferrin,  as  well  as  reference 
standards were provided by our department of clinical chemistry. 
Immunofluorescence was carried out with goat antiserum to human lactoferrin. The immunoglob- 
ulins, prepared by successive precipitation with rivanol and ammonium sulfate,  were labeled with 
fluorescein isothiocyanate at a ratio of 10 pg of fluorochrome/1 mg of protein. 
Animals.  All the rats used for the present work were 3-mo old Wistar females weighing about 200 
g.  Intravenous injections were  done via the tail vein. For repeated blood sampling from the same 
animal, the tip of the tail was bled into heparinized hematocrit tubes. Exsanguination was performed 
by puncturing the aorta. 
Processing of Leukocytes.  Human leukocytes from venous blood were separated from red cells by 
accelerating the sedimentation by means of dextran,  as previously described  (9).  Rabbit and rat 
heterophil leukocytes were harvested from peritoneal exudates, following the procedure described by 
Hirsch (20). Cells were disrupted by freezing and thawing six times, and extracted by means of 1 M 
saline (9). 
Analytical Methods.  Immunoassays were performed by radial diffusion (21) or nephelometry in 
the Technicon Auto Analyzer (Technicon Instruments Corp.,  Tarrytown, N. Y.)  (22,  23). Reference 
standards for the determination of rat lactoferrin were set up using an extract from rat leukocytes. 
The  lactoferrin  content  of  this  material  was  estimated  by  densitometry  scanning  (Analytrol, 
Beckman Instruments, Inc., Fullerton, Calif.) of electrophoreses on cellulose acetate, using human 
lactoferrin as a  standard.  The electrophoretic band corresponding to lactoferrin was  identified by 
autoradiography, as described in the Results. Lysozyme activity was estimated by radial diffusion in 
agarose  gel  containing  Micrococcus  lysodeikticus  (24).  Alkaline  phosphatase  was  determined 
enzymatically with p-nitrophenyl phosphate as the substrate (Merckotest; E. Merck AG, Darmstadt, 
W. Germany). X-ray films routinely used in clinical departments were employed for the autoradiog- 
raphies. ~gFe of high specific activity was used in the form of ferric citrate. 
Blockade of the RES.  The RES of rats was blocked by intravenous injections of carbon particles, 1070  J.  L.  VAN SNICK,  P.  L.  MASSON~ AND J.  F.  HEREMANS 
following the procedure described by Biozzi et al. (25).  Carbon particles (Cl1-1431A India ink from 
Gunther Wagner, Hannover, W. Germany), were centrifuged at 5,000 rpm for 15 min to eliminate the 
largest fragments (more than  25  nm),  and  were suspended in  saline containing 2%  gelatin  in  a 
proportion of 30 mg of carbon/ml. This preparation was stored in the cold, and was melted at 37°C 
before use. In the initial experiments, blockade of the RES was obtained by three injections of 30 mg 
of the colloid at 8-h intervals. It later appeared that a single injection was sufficient. 
In  order to detect possible specific interference of carbon particles with immunoassays, some 
experiments of RES  blockade were also performed by single intravenous injections of aggregated 
human albumin. The latter protein, at a concentration of 30 mg/ml in saline, was aggregated at pH 
10.0 by heating at 70°C for 20 min and then at 79°C for another 15 min, under permanent shaking at a 
rate of 100 times/min (26). Aggregation was monitored by the increase of absorbance at 520 min. After 
adjusting the pH at 7.5,  the colloid was stored at 4°C until use. 
Results 
In Vitro Experiments 
Release of Apolactoferrin by Neutrophil Leukocytes. The release of lactofer- 
rin by rabbit heterophils was studied on cells collected from peritoneal exudates. 
On the average, about 0.5  ×  109 cells consisting for more than 90.°/o of heterophils 
were  obtained  from  one  animal.  After  brief  centrifugation,  the  cells  were 
suspended in saline enriched with 5% glucose and separated into two fractions. 
The final cell number ranged from 10 to 40 ×  10e/ml.  One part of the suspension 
was incubated at 37°C with 100 mg of zymosan, the rest being used as a control. 
Both samples were centrifuged after 45 min. The cell pellets were discarded and 
determinations of lactoferrin, lysozyme, and alkaline phosphatase were carried 
out on the supernates. Lactoferrin was measured by radial immunodiffusion, and 
its concentration was  expressed in  micrograms per  milliliter, with extracts of 
rabbit  neutrophils  as  standards,  assuming  the  lactoferrin  content  of rabbit 
heterophils to be similar to that of human neutrophils, i.e., 3.4 gg of lactoferrin/ 
l0  s cells. The induction of phagocytic activity by zymosan caused the simultane- 
ous release of lactoferrin, lysozyme, and alkaline phosphatase, as well as a slight 
decrease in the pH of the medium (Table I). 
TABLE I 
Changes in the Concentration of Lacto[errin,* Enzymes, and Hydrogen Ion in the 
Medium  Upon Incubation of 0.5  x  10 ~ Rabbit Heterophil Leukocytes 
with Zymosan 
Lactoferrin (#g/ml)  Lysozyme (~g/ml)  Alkaline phosphatase  pH 
(mU/ml) 
Phago-  Control  Phago-  Control  Phago-  Control  Phago-  Control 
eytosis  cytosis  cytosis  cytosis 
246  36  102  44  --  --  6.9  7.3 
102  23  81  32  --  --  7.8  8.0 
38  21  61  30  130  60  6.8  6.9 
* Extracts of neutrophils were used as standards, with the assumption that 10' neutrophils contained 
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An  experiment  with  human  neutrophils  was  also  carried  out.  The  cells 
harvested from 100  ml of venous blood were exposed to Staphylococcus  albus 
which had been killed by heating. The leukocytes were resuspended in 1 ml of 
plasma. One half of each sample was mixed with 20 ~1 of the pellet of bacteria, 
the rest serving as a control. After I h of incubation at 37°C, lactoferrin was found 
to have reached a  concentration of 100 ~g/ml in the fluid phase of the sample 
exposed to bacteria, against only 17 ~g/ml in the control. 
To  verify  whether  the  lactoferrin  discharged  from  neutrophils  was  in  the 
iron-free form or fully saturated with metal, a leukocyte extract was prepared to 
which [59Fe]citrate was added. Leukocytes were isolated from 100 ml of human 
blood and lactoferrin was extracted as described in the Materials and Methods. 
Special care  was taken to avoid contamination with iron from glassware or 
reagents. In order to eliminate the traces of metal ordinarily present in saline (0.5 
mg iron/g of NaC1), the solutions used for washing the cells and extracting the 
proteins  were  passed  over  a  column  of  apolactoferrin  coupled  to  Sepharose 
(unpublished observations). To remove plasma proteins, the pellet of leukocytes 
(about 100 ~1) was washed three times with 0.15 M saline and extracted with I ml 
of 1 M  NaC1,  after which 400  nmol of ~gFe in 0.5  M  citrate was added to the 
sample. 
The  proteins  were  separated  from  the  Fe-citrate  complex  by  filtration on 
Sephadex G25  which had been equilibrated with 1 M  NaC1 containing 0.05  M 
citrate,  a  concentration of chelator known to  prevent the  formation of ferric 
citrate polymers (27). Fractions of 0.5 ml were collected, counted for radioactiv- 
ity,  and assayed for lactoferrin by nephelometry. All the iron eluted with the 
proteins  was  bound  to  lactoferrin,  since  the  latter  was  the  only radioactive 
protein detectable by electrophoresis on cellulose acetate of similar extracts. In 
particular,  the  absence  of  transferrin  in  the  sample  was  verified  by  an 
immunologic precipitin test. 
From the Fe to lactoferrin ratio in the various fractions eluted from Sephadex 
G25,  it was evident that the lactoferrin extracted from the leukocytes had fixed 
59Fe up to 92% (SD, 9.3%)  of its iron-binding capacity. 
Exchange of Iron between  Transferrin and Lactoferrin.  Apolactoferrin and 
half-saturated ~gFe-labeled transferrin were mixed in equal proportions (5 mg/ml 
for each).  After l-h incubation at 37°C,  in various media,  the lactoferrin and 
transferrin from 1-ml portions of the mixture were separately removed by means 
of  short  immunosorbent  columns  made  with  the  appropriate  antisera  and 
equilibrated with the same medium as that used for the incubation. The recovery 
of each protein, after elution with 3 M ammonium thiocyanate, was monitored by 
the absorbance at 280 nm, and the radioactivity in each eluate was counted. 
The results (Table II) showed that in the absence of citrate, lactoferrin was 
unable  to  remove  any  iron  from  transferrin  at  pH  7.3  (0.01  M  phosphate), 
whereas 50% of the transferrin iron was passed on to lactoferrin at pH 6.65 (0.01 
M  phosphate), and 75% at pH 5.6 (0.1 M  acetate buffer). In the presence of 10 
mM  citrate,  these  proportions became approximately 50%  (pH 7.3),  50%  (pH 
6.6), and 95% (pH 5.6), respectively, indicating a facilitating effect of the chelator 
during the iron exchange. 
In an attempt to reproduce physiopathological conditions, experiments were 1072  J.  L.  VAN SNICK,  P.  L.  MASSON,  AND J.  F.  HEREMANS 
TABLE II 
Uptake of 59Fe by Lactoferrin from 50% Saturated  Transferrin 
pH 7.3  pH 6.6  pH 5.6 
No citrate  0-4*  57-58  73-79 
Citrate ( 10 mM)  47-53  39-54  94-95 
Pus ultrafiltrate  57-58 
* Percent of the iron originally bound to transferrin. 
also performed with lactoferrin and transferrin dissolved in the ultrafiltrate from 
a purulent pleural exudate. The pH of this medium was 6.6. The amount of iron 
removed by lactoferrin was found to be 57-58% of the metal originally present on 
transferrin. 
The latter experiment was repeated with human serum at pH 7.4 containing 
2.9  mg/ml of 35%  saturated transferrin. The sample (4 ml) was labeled with a 
trace  amount of ~gFe (100  ul  of ~gFe in  0.025  M  citrate).  Apolactoferrin was 
dissolved in the serum to a  final concentration of 3 mg/ml. After a  1-h or 4-h 
incubation at 37°C, lactoferrin and transferrin were extracted by immunosorb- 
ents.  In four different experiments it was found that lactoferrin had acquired 
2.5-10% of the iron originally present on transferrin. 
Uptake  of Lactoferrin  by Mononuclear  Blood  Cells.  Human Fe-lactoferrin 
was added,  to a  final concentration of 5 mg/ml, to human leukocytes isolated 
from 10 ml of blood and suspended either in 4 ml of plasma or 0.15 M  saline. In 
the first experiment, in order to prevent pinocytosis of the protein, the leukocytes 
were exposed to lactoferrin in the cold (4°C) and were then washed three times 
with cold saline; the cell pellet was resuspended in cold fluorescein-labeled goat 
antiserum to lactoferrin, and again incubated for 1 h at 4°C. After washing with 
cold isotonic saline, a  drop of the cell suspension was examined under the UV 
microscope. Thin crescents of fluorescence were seen surrounding mononuclear 
cells (Fig. 1).  This typical membrane fluorescence was not visible on cells that 
had  not  been  exposed  to  lactoferrin. Nonspecific adsorption by leukocytes of 
fluorescent antibodies was also ruled out by the absence of fluorescence on cells 
incubated  with  fluorescein-labeled  immunoglobulins from  a  goat  immunized 
against albumin. When examined by phase contrast, the lactoferrin-binding cells 
were identified as monocytes on the basis of their size and the shape of their 
nuclei (Fig. 1). 
In a second experiment, the leukocytes were exposed to Fe-lactoferrin at 37°C 
for 1 h. After three washings the cells were spread on microscope slides, dried, 
and  fixed  for  3  min  in  absolute  methanol.  The  smear,  washed  with  0.02  M 
S~brensen phosphate  buffer,  pH  7.2,  was then stained with fluorescein-labeled 
antiserum to lactoferrin. Patches of fluorescence were visible in the cytoplasm of 
two  types  of  cells,  some  clearly  neutrophils,  and  the  others  having  the 
morphology of monocytes (Fig. 1). On the control smear prepared with leukocytes 
not exposed to lactoferrin, only neutrophils were fluorescent. The specificity of 
the fluorescence observed in these two experiments was attested by the lack of LACTOFERRIN IN  INFLAMMATION  1073 
Fro.  1.  Human  blood monocytes having fixed  (A  and  B)  or ingested (C  and  D)  human 
lactoferrin (revealed by fluorescein-labeled goat antiserum to human lactoferrin; B and D are 
phase-contrast photographs of A and C, respectively}. A and B are living cells from buffy coats 
suspended in saline after exposure to a 0.3% solution of lactoferrin in serum for 1 h at 4°C, 
followed by  washing  with  saline,  and  vital  surface  staining  at  4°C  with  fluoresceinated 
antiserum. C and D are dried, fixed, fluoresceinated antiserum-stained cells from buffy coats 
that had been suspended in a 0.3% solution of lactoferrin in serum for 1 h at 37°C. 
staining  when  the  smears  were exposed to the  same  antilactoferrin  antiserum 
previously absorbed on a  column of lactoferrin coupled to Sepharose. 
In Vivo Experiments 
Hyposideremia  Induced  by Exogenous  Apolactoferrin.  The  intravenous  in- 
jection into rats  of 15  mg of human  native apolactoferrin dissolved  in  1  ml of 
saline caused on the average a 46% decrease in the plasma iron level measured 4 h 
after the injection (Table III). Human Fe-lactoferrin or human serum albumin, 
at  the  same  dose  did  not  cause  any  change,  whereas  human  apotransferrin 
induced an increase of about 32%  (0.1  <  P  <  0.2). 
When  graded  amounts  (5,  10,  or  15 mg)  of apolactoferrin were injected,  the 
effect on the iron level was related to the dose of the protein (Fig. 2). For doses of 
5 or 10 mg the plasma iron appeared to reach its minimum 2 h after the injection. 1074  J.  L.  VAN SNICK,  P.  L.  MASSON,  AND J.  F.  HEREMANS 
TABLE  III 
Plasma Iron Levels ~g/lO0 ml) of Rats 4 h after 15-mg Injections 
of Protein 
Apo-lac-  Fe-lac-  Apo-trans-  Albumin  Nil 
toferrin  toferrin  ferrin 
Mean  133.3  267  323  259.5  244 
SD  38.7  44.5  40  32  23.4 
Range  74-210  210-302  273-378  220-304  188-273 
n  9  3  4  4  10 
For 15 mg of apolactoferrin the hyposideremia continued unabated for at least 4 
h.  With the latter dose, but not with the smaller doses, significant amounts of 
lactoferrin  were  still  detectable  in  the  plasma  2  h  after  the  injection.  This 
suggested that what really mattered for the removal of iron from the circulation 
was  not  so  much  the  amount of apolactoferrin  injected  or  remaining in  the 
circulation, as the quantity of the protein that had been cleared from the blood 
within the period of observation. This assumption was tested by determining the 
lactoferrin content of the  plasma at different time intervals and for different 
doses of apolactoferrin injected. The plotting of these data (Fig. 3) brought out a 
strikingly linear correlation between the amounts of iron and lactoferrin cleared 
from the plasma. From this diagram, it appeared that the removal of 0.37 ttg of 
iron corresponded to the clearance of 1 mg of lactoferrin. Hence lactoferrin, which 
is  able  to  bind  1.4  ttg  of  iron/mg,  was  eliminated  at  a  saturation  level 
corresponding to about 40% of its iron-transporting capacity, taking into account 
that the native apolactoferrin used in these experiments was saturated at 13% of 
its capacity when injected (see Materials and Methods). 
Clearance of Exogenous Lactoferrin.  Various human proteins (15 mg in 1 ml 
of saline)  were  injected  intravenously into  rats  and  their  concentration was 
determined by nephelometric immunoassay in blood samples collected at regular 
intervals.  Differences between the  rates  of elimination of these proteins were 
particularly marked in the first part of the clearance curves. Over the first 90 min 
these curves were simple exponentials (Fig. 4) from which an "initial half-life" 
could  be  calculated.  The  initial  half-life  of  Fe-lactoferrin  (Table  IV)  was 
particularly short (33 min; SD, 1.6 min), compared to that of Fe-transferrin (243 
min;  SD,  78  min)  or  albumin  (165 min;  SD,  34  min).  When  the  sample  of 
lactoferrin injected was nearly devoid of iron (native apolactoferrin), its initial 
half-life was significantly increased (53 min; SD, 3.8 min). This dependance of 
the rate of clearance on the degree of saturation with iron was confirmed by the 
results obtained with half-saturated lactoferrin whose half-life (44  min; SD,  3 
min) was found to be intermediate between that of Fe-lactoferrin (P <  0.01) and 
that of native apolactoferrin (P -~ 0.05). Succinylation of Fe-lactoferrin markedly 
prolonged its initial half-life (103 min; SD,  13.4 min), although its iron content 
(95%) remained unaltered by this treatment. 
When the RES of the animals was blocked by India ink or aggregated albumin, 
the half-life of Fe-lactoferrin respectively increased about threefold (90 min; SD, 
25 min) and fourfold (110 min; SD, 26 min). O 
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FIG.  2.  Decrease of serum iron in rats after the intravenous injection of various amounts (5, 
10, or 15 mg) of human apolactoferrin in saline. Vertical bars indicate the + 1 SD range. From 
3 to 10 rats were used for each determination. 
Uptake  of Endogenous  Fe-Lactoferrin  by the RES 
IDENTIFICATION  OF  LACTOFERRIN  FROM  HETEROPHILIC  LEUKOCYTES  OF  THE 
RAT.  When  extracts  from  peritoneal  leukocytes of rats  were  fractionated  by 
cellulose acetate electrophoresis at pH 8.5,  two very closely spaced and poorly 
resolved cathodal  bands of equal  intensity could be distinguished.  Both bands 
showed up on X-ray films after addition of 59Fe to the sample (Fig. 5). 
The  goat  antiserum  against  extracts  from  rat  leukocytes developed several 
precipitin lines with this material. Among these antigens, the one that migrated 
towards the cathode was capable of binding ~Fe, as indicated by a autoradiogra- 
phy  from  the  immunoelectrophoresis  (Fig.  6).  An  antiserum  prepared  by 
injecting this cathodal protein into a rabbit (see Materials and Methods) formed 
a single precipitin line with rat leukocyte extracts. This line blended with that of 
the iron-binding  protein precipitated by the unspecific goat antiserum.  Further 
proof of the identity of this protein with lactoferrin was furnished by the finding 
that  goat  antiserum  to human  lactoferrin  developed,  in the  leukocyte extract 
from rats, a precipitating line merging with the one formed by the monospecific 
rabbit antiserum  (Fig. 7). 
EXTRACTION  OF  LACTOFERRIN FROM THE  LIVER,  LUNG,  KIDNEY,  AND SPLEEN  OF RATS 
INJECTED WITH ENDOTOXIN.  Endotoxin  (0.5 mg in 1-ml saline) was injected into 
the peritoneal  cavity of six rats.  After 6 h  the animals  were killed by bleeding. 
Their liver, spleen,  lungs, and kidneys were removed, homogenized, frozen, and 
thawed  six  times,  and  extracted  with  1 M  saline.  The  insoluble  fraction  was 
discarded  by  centrifugation  at  20,000  rpm  for  50  min.  The  concentration  of 
lactoferrin  was  determined  by nephelometric  immunoassay  in  the  supernates 
after appropriate  dilution. 1076 
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FIG.  3.  Proportionality between the amounts of serum iron and apolactoferrin cleared from 
the plasma. The stippled lines delineate the  ±2 SD range. The dots represent mean values 
from 3 to 10 individual animals. 
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The injection of endotoxin caused the plasma iron concentration to fall from 
2.4 (SD,  0.2) to 1.2 (SD,  0.22) #g/ml. On the average, 2.6 mg of lactoferrin (SD, 
0.34 mg) was recovered from the liver, 1.5 mg (SD, 0.29 mg) from the lungs, and 
0.26 mg (SD, 0.04 mg) from the kidneys of the animals injected with endotoxin, 
whereas no lactoferrin was demonstrable by immunoelectrophoresis (Fig. 8)  or 
immunonephelometry in the extracts of the liver or lungs of four normal rats. 
Some  lactoferrin  was  detected  in  spleen  extracts  from  normal  rats  (0.12 
mg/spleen; SD, 0.03 mg) whereas twice that amount was present in the spleen of 
the animals injected with endotoxin. From these data it may be estimated that 
endotoxin is capable of causing the appearance of at least 4.3 mg of additional 
lactoferrin  in  the  organs  of the  rat.  When  pgFe]citrate  (5  #Ci)  was  injected 
intravenously into rats 30 min before the administration of endotoxin, the isotope 
was found to be associated with the lactoferrin extracted from the lungs and liver, 
as  shown  by  autoradiography of the  immunoelectrophoreses,  developed  with 
rabbit antiserum against rat lactoferrin. LACTOFERRIN  IN INFLAMMATION  1077 
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FIG. 4.  Clearance of various proteins from the circulation in rats intravenously injected with 
15  mg of,  respectively:  (A),  Fe-Tf,  iron saturated  human  transferrin  (3 rats);  (O), Apo-Lf, 
human lactoferrin (87% iron-free--7 rats); (O), Fe-Lf, human lactoferrin saturated with iron (8 
rats);  and  (I),  Alb,  human  serum  albumin  (4  rats).  Clearance  curves  (solid  lines)  were 
computed by least-square fitting to an exponential decay equation. 
DETECTION OF LACTOFERRIN IN THE BLOOD  OF  RATS  WITH  A  BLOCKED  RES.  Since 
lactoferrin  was  suspected  to  be  eliminated  by  the  RES,  experiments  were 
undertaken on seven rats  whose RES  had  been blocked by three injections of 
India ink.  Endotoxin (0.5  mg in  1 ml  of saline)  was  injected intraperitoneally 
immediately after the last administration of colloid. The blood was collected 4 h 
later  and  the  concentration  of lactoferrin in  the  plasma  was  determined  by 
nephelometric immunoassay.  A  mean  concentration of 58  #g/ml  (SD,  7)  was 
found, whereas no lactoferrin ( < 10 ~g/ml) was detectable in the plasma of three 
animals injected with endotoxin but with an intact RES, nor in that of normal, 
untreated rats. The lactoferrin revealed by immunoelectrophoresis of the plasma 
from animals with blocked RES showed an erratic mobility (Fig. 8) as it migrated 
in the a2-region. This change in the electrostatic charge of lactoferrin was due to 
interaction with albumin,  as shown by immunoelectrophoretic experiments on 1078  J.  L.  VAN SNICK,  P.  L.  MASSON,  AND J.  F.  HEREMANS 
TABLE  IV 
Intial Half-Lives of Various Human Proteins in Rats 
Initial  No. of 
Proteins  SD  half-life  rats 
100%saturated lactoferrin 
50%saturated lactoferrin 
13%saturated lactoferrin 
Succinylated Fe-lactoferrin 
rain  rain 
33  1.6  8 
44  3  4 
53  3.8  7 
103  13.4  4 
Fe-transferrin  243  73  3 
Albumin  165  34  4 
Fe-lactoferrin after blocking the RES with 
India ink 
Aggregated albumin 
90  25  3 
110  26  3 
Fro.  5.  Cellulose acetate electrophoresis (pH 8.6) of: LE,  rat leukocyte extract; LF, human 
lactoferrin; and SE,  rat serum. Left, stained for protein (Ponceau Red). Right, autoradiogra- 
phy. Arrows, the two lactoferrin components of rat leukocytes. 
artificial  mixtures  containing  different  proportions  of  leukocyte  extract  and 
human  serum albumin  (see Fig. 8). 
Discussion 
From  our  in  vitro  experiments  it  appears  that  iron  is  effectively removed  by 
apolactoferrin from transferrin only at pH values below 7, and that this exchange 
is greatly facilitated by the presence of chelators.  It is generally admitted that LACTOFERRIN  IN  INFLAMMATION  1079 
Fro.  6.  Immunoelectrophoretic analyses of rat leukocytes extracts (A, B, C) developed with: 
ALE, goat antiserum to rat leucocyte extract; and ALF, rabbit antiserum to rat lactoferrin. A 
and C  stained for protein (Amido Black) and B, autoradiography of A. 
Fro.  7.  Immunologic identification of rat leukocyte lactoferrin. RLE, rat leucocyte extract; 
ARL, rabbit antiserum to rat lactoferrin; and AHL,  goat antiserum to human lactoferrin. 
low pH levels prevail in inflamed tissues, due to the release of lactic acid by the 
accumulating stimulated polymorphonuclear leukocytes (28). Therefore, at such 
sites, e.g. in abscesses, one would expect an exchange of iron to occur between the 
Fe-transferrin adduced from the plasma and the apolactoferrin released by the 
leukocytes. The  iron-chelating capacity of the lactic  acid set  free on  such an 
occasion may conceivably assist in this process. 
However,  in systemic inflammatory reactions such as that caused by endo- 
toxin, a lowering of the pH in any region of the organism has, to our knowledge, 1080  J.  L.  VAN  SNICK,  P.  L.  MASSON,  AND J.  F.  HEREMANS 
FIG. 8.  Immunoelectrophoretic  analyses, by antiserum  to rat lactoferrin, of: A and B, liver 
extracts from endotoxin-treated  (A) and untreated  (B) rats; C, plasma from an endotoxin- 
treated rat with blocked RES;  and D, rat leukocyte extract diluted  in normal rat serum to 
reproduce  the abnormally fast electrophoretic  mobility  of lactoferrin  seen in C and due to 
interaction  of lactoferrin with serum proteins. 
never  been  reported.  A  change  in  pH  seems  even  more  unlikely  in  the 
hyposideremia caused by the injection of apolactoferrin.  Nevertheless,  as shown 
by our results and discussed hereafter, apolactoferrin originating from leukocytes 
is  clearly  the  factor  which  removes  the  iron  from  the  circulation.  A  plausible 
explanation  may reside  in  the  particularly  high  rate  at which  Fe-lactoferrin  is 
cleared from the blood,  together with the metal it has taken up.  As a  result,  the 
equilibrium  of the exchange reaction, 
TfFe2  +  Lf ~  Tf +  LfFe2, 
is  constantly  shifted  to  the  right,  because,  as  soon  as  LfFe2  is  formed,  this 
molecular species is preferentially removed. This is shown by a comparison of the 
clearance rates of Lf and LfFe2 (Table IV). Equilibrium constants for the binding 
reactions of these two proteins at neutral pH are unfortunately not available, but 
it is known that in the pH 6.4-6.7 range, the equilibrium  constant KI for Fe 3÷ is 
about  300  times  larger for lactoferrin than for transferrin  (29).  Incidentally,  the 
iron-chelating citrate  molecule occurs in human  plasma at the concentration  of 
about 0.1 mmol/liter (30). 
In regard to the fall in the iron content of the plasma that was induced by an injection of 
apolactoferrin, several convergent data indicate that this effect actually resulted from the 
direct action of exogenous apolactoferrin and not from an inflammatory reaction caused 
by  the  inadvertent  introduction  of  some  bacterial  toxin  contaminating  the  protein LACTOFERRIN  IN  INFLAMMATION  1081 
solution:  (a) A sample of lactoferrin from the same batch but saturated with iron did not 
change the plasma iron level. The iron present in the protein could not interfere with the 
determination, since, at the time of the assay most of the Fe-lactoferrin injected (97%) had 
already been eliminated. (b) Injections of proteins other than lactoferrin did not decrease 
the  plasma  iron  level,  which  to  the  contrary  was  found  to  rise  after the  injection  of 
apotransferrin. The latter finding could be explained by the capability of transferrin to 
mobilize storage  iron  (31).  (c)  It is known  that  the  effect of an intraperitoneal  dose of 
endotoxin  on  the  serum  iron  level  does not  reach  its  maximum before 8-12  h  (5).  In 
contrast, the hyposideremia caused by exogenous apolactoferrin was already detectable 2 
h  after the injection.  (d)  Finally, the lowering of serum iron was linearly related to the 
amount of exogenous lactoferrin cleared from the blood (Fig. 3). 
The specificity of the affinity of lactoferrin for macrophage membranes, shown by 
our data,  must be scrutinized in the light of the knowledge that macromolecules 
with  a  high net-positive charge are preferentially bound  and engulfed by these 
cells  (32).  However,  the  fact  that  lactoferrin  was  cleared  faster  in  its  iron- 
saturated  form than  when  iron-free,  seems to  imply the  existence  of a  specific 
receptor on the membrane of macrophages as well as a corresponding binding site 
on the molecule of lactoferrin.  Succinylation,  which was found to slow down the 
clearance  of lactoferrin,  presumably altered the regions involved in the binding 
reaction. 
As mentioned in the introduction, the trapping of serum iron, under the form of ferritin, in 
inflammatory loci as well as in organs rich in reticuloendothelial cells, e.g. the liver and 
spleen,  is a  typical feature of inflammation  (3,  4).  In the light of our results,  it seems 
probable  that  the  lactoferrin-binding  macrophage is the  cell causally involved in  this 
phenomenon.  Whether  Fe-lactoferrin  constitutes  a  stimulus  for  the  biosynthesis  of 
apoferritin remains to be verified. What is clear from our data is that large amounts of 
Fe-lactoferrin appear in the liver, spleen, and lungs at a very early stage of the systemic 
inflammatory syndrome induced  by the injection of endotoxin.  Some of the lactoferrin 
extracted from these organs in our experiments doubtlessly originated from the disruption 
of the  polymorphonuclear leukocytes  that  infiltrated  the  tissues  due  to  the  systemic 
inflammatory  condition.  However,  this  can  only  account  for  a  mere  fraction  of the 
lactoferrin  extractible  from  these  tissues,  since  the  average  lactoferrin  content  of 
polymorphonuclear leukocytes, viz. 3 ug/108 cells (9), would require the presence of a far 
larger number of such cells in the organs involved than was actually seen in histological 
sections {unpublished observations). Moreover, this tissue lactoferrin was found to carry 
the radioactive iron previously present on serum transferrin, whereas leukocyte lactoferrin 
should have been essentially iron-free and should not have been able to take up the 59Fe 
present in the preparation under the alkaline extraction conditions (pH 8.2) employed. All 
this leads to the conclusion that the major part of the tissue lactoferrin must have been 
present  in  or  on  macrophages.  Immunohistological  studies  now  in  progress  fully 
substantiate this view. 
In conclusion,  apolactoferrin  released  by neutrophilic  leukocytes appears to be 
the agent responsible for the accumulation of iron in the RES during inflamma- 
tion.  Since the organism, for reasons still unknown,  preferentially draws the iron 
needed  for  the  biosynthesis  of hemoglobin  from destroyed  erythrocytes rather 
than from the iron stores (33), the interference of lactoferrin with the metabolism 
of this metal might explain why inflammation causes hypochromic anemia. 1082  J.L.  VAN SNICK,  P.  L.  MASSON,  AND J.  F.  I-IEREMANS 
Summary 
The  hyposideremia of inflammation  was  found  to  be  based  on  a  three-step 
mechanism  involving  lactoferrin,  the  iron-binding  protein  from  the  specific 
granules of neutrophilic leukocytes. 
(a) Lactoferrin  is  Released from  Neutrophils  in  an Iron-Free Form.  When 
phagocytosis was induced in neutrophils by zymosan or bacteria, lactoferrin was 
recovered in  the  incubation  medium  together with  other  constituents  of the 
specific  granules,  such  as  alkaline  phosphatase  and  lysozyme.  Lactoferrin 
extracted from leukocytes was able to bind the amount of iron corresponding to 
its  theoretical  iron-binding  capacity.  After  injection  of endotoxin  into  rats, 
lactoferrin was detected in various tissues where it was normally absent, or in the 
plasma when the reticuloendothelial system (RES) had previously been blocked 
by injections of India ink or aggregated albumin. 
(b)  Lactoferrin  is  Able  to  Remove  the  Iron  from  Transferrin.  Significant 
exchange of iron from transferrin to lactoferrin was observed in vitro only at a pH 
below 7.0 or in the presence of a high concentration of citrate. However, the fast 
elimination of lactoferrin in vivo, when saturated with iron, might account for the 
observed transfer of iron to endogenous or administered apolactoferrin. Intrave- 
nous injection of human apolactoferrin into rats caused a marked decrease of the 
plasma  iron  level. The kinetics of this  process,  as  well  as  controls with  other 
proteins,  ruled  out  the  possibility of a  secondary inflammatory effect due  to 
phlogogenic contaminants. 
(c) Fe-Lactoferrin is Taken-up  by the RES. By immunofluorescence, lactofer- 
rin was shown to be bound and ingested by monocytes. The rate of elimination of 
human Fe-lactoferrin injected into rats was particularly fast when compared to 
that  of  human  apolactoferrin,  succinylated  Fe-lactoferrin,  or  other  human 
proteins. Blockade of the RES slowed down the rate of clearance of Fe-lactoferrin 
and  was  also  found  to  retard  the  elimination  of endogenous  rat  lactoferrin 
released  by  endotoxin.  These  experiments  suggest  the  existence  of  specific 
receptors for Fe-lactoferrin on the membrane of macrophages. 
The authors wish to  thank Mrs.  Brigitte Mertens de  Wilmars-de Lestr~ for her skillful technical 
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